Our mission is to measure and monitor steroid-toxicity, optimize treatment of inflammatory diseases, and improve the standard of care for millions of patients around the world.
We developed the Steritas GTI (Glucocorticoid Toxicity Index) to enable clinicians to track the direct impact of steroid-toxicity.
Today, the GTI provides a precise measure of the efficacy and safety of new therapies that treat inflammatory diseases and minimize the side-effects associated with glucocorticoid use.
We aim to provide clinicians and patients the ability to track steroid-toxicity so they can taper steroid usage, and optimize treatment for the best possible outcomes.
Company Details
- Employees
- 4
- Founded
- 2020
- Address
- Boston, Ma, Us
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://www.steritas.com
- Keywords
- Denver.
- HQ
- Boston, MA
Steritas Questions
Steritas's website is http://www.steritas.com
Steritas's LinkedIn profile is https://www.linkedin.com/company/steritas
Steritas has
4 employees.
View email and phone details for 4
employees at Steritas.
Steritas's industry is
Hospitals and Health Care
Steritas's top competitors are
Ingenious Agency,
Future Medical Research,
Aplar Rheumatology Congress,
American College Of Rheumatology,
Ussonar,
Onconox Inc.,
Aplar,
Argenx,
Bristol Myers Squibb,
Hinge Bio.
Steritas's categories are Hospitals and Health Care
Steritas's founding year is 2020
